What a heartfelt response, grateful for each voice message, email, text, post reply, repost and hug that I have received for this news. It means more than you can imagine.
When we started embarking on this NIH SBIR journey, we faced a choice: play it safe with a Phase I or leap into a Direct-to-Phase II. Despite convention and recommendations to be more cautious as this would be our first submission ever to the NIH, internally and with our amazing advisors we had confidence in our readiness. You all know, my team and I have been all but conventional, through this journey we’ve had the privilege of working with talented people. Awesome people together, can achieve great things. We decided to go for the steeper Direct-to-Phase II path and we were supported by visionary, experienced clinical partners who dedicated a lot of time to support our efforts to submit an application so we can advance cardiovascular care for women. Fast forward many reviewers (>30) and a promising high impact score later ...we received the recommendation to re-submit (yeah I wasn’t expecting that either, but it happens...) feedback was great, so we iterated and resubmitted. Taking risks is never easy, and challenges always present just before the rewards. It worked!
Receiving the Notice of Award for a Direct-to-Phase II to propel our progress is SO exciting. What we will learn from the clinical study will enable us to further generate novel digital biomarkers for women’s health to improve outcomes in her personal heart story. Everyone that supports our work at Bloomer Tech adds strength to the future we envision. Your impact is immeasurable, and I am grateful beyond words. Every step of the way we have gained strength by surrounding ourselves with you. So again thank you for celebrating this news with us! 🌟 #Gratitude #CommunityPower
Bloomer Tech has received a $1.9M grant from The National Institute of Health!
Heart disease in women is harder to recognize, diagnose, and treat, and there is a huge opportunity for innovation and focus towards new female-specific solutions.
We are collaborating with #UFHealth and #Lakeland Regional Health-Florida to enroll female patients for a clinical trial using our Tech-Augmented Garment (TAG) which is designed to acquire high quality, medical-grade data from female physiology in the form of an everyday bra.
We’re excited to be awarded this grant to revolutionize women’s health and advance cardiovascular care among women.
Read more about the news: https://lnkd.in/e2kzk7Ej
#NIH #SBIR #womenshealth #hearthealth
Alicia Chong Rodriguez Ruby Khalaf, MSc, MPH Aceil Halaby Cindy Eveleigh
Bloomer Tech Receives $1.9M From NIH for a Clinical Study in Women's Heart Health
einpresswire.com